| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |